Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The Aurum Institute is a leading African-led global health organization and research institute dedicated to the eradication of tuberculosis (TB) and HIV. Established in 1998 as a spin-off from Anglo American's health services, the institute operates as a non-profit company that bridges the gap between scientific research and large-scale public health implementation. It specializes in conducting high-impact clinical trials, epidemiological studies, and health systems strengthening initiatives across sub-Saharan Africa and globally. Aurum is a primary partner for major international agencies, including the Bill & Melinda Gates Foundation, USAID, and the CDC, playing a pivotal role in evaluating new diagnostics, vaccines, and drug regimens. The organization is particularly recognized for its expertise in implementation science, ensuring that evidence-based medical interventions reach vulnerable populations effectively.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Aurum Institute.